The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies - Passweg, J R; Baldomero, H; Basak, G W; European Society for Blood and Marrow Transplantation (EBMT) (Bone Marrow Transplant, 2019)